Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Jiang, Yong ^a   Wang, Hui Yan ^a   Cao, Hong Mei ^a   Wang, Chun Yan ^a   Zhang, Lei ^a   Wang, Hao ^a   Liu, Lei ^a   Li, Yan ^a   Cai, Jian Hui ^a  

^a JILIN MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; MICRORNA; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); TROPONIN T;

ATHEROSCLEROSIS; BLOOD; CASE CONTROL STUDY; CHRONIC DISEASE; COMPARATIVE STUDY; DIABETES MELLITUS; DISEASE COURSE; FOLLOW UP; GENETICS; HUMAN; HYPERLIPIDEMIAS; HYPERTENSION; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHRONIC DISEASE; DIABETES MELLITUS; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MICRORNAS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; ROC CURVE; TROPONIN T;

EID: 84901291478     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05026     Document Type: Article

References (32)

1. Shah, A. S. et al. Global association of air pollution and heart failure: a systematic review and meta-analysis. Lancet 382, 1039-1048 (2013).
2. Go, A. S. et al. Executive summary: heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 127, 143-152 (2013).
3. Wei, Y., Nazari-Jahantigh, M., Neth, P., Weber, C. & Schober, A. MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis? Arterioscler Thromb Vasc Biol 33, 449-454 (2013).
4. Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809 (1993). (Pubitemid 23132154)
5. Maisel, A. S. et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347, 161-167 (2002). (Pubitemid 34764819)
6. Tsutamoto, T. et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 96, 509-516 (1997). (Pubitemid 27329427)
7. Maisel, A. S. et al. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. Am Heart J 147, 1078-1084 (2004). (Pubitemid 38880968)
8. Daniels, L. B. et al. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study. Am Heart J 151, 999-1005 (2006).
9. Vickery, S. et al. B-type natriuretic peptide (BNP) and amino-terminal pro-BNP in patients with CKD: relationship to renal function and left ventricular hypertrophy. Am J Kidney Dis 46, 610-620 (2005). (Pubitemid 41383938)
10. Jafri, L. et al. B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function. BMC Nephrol 14, 117 (2013).
11. Tanasijevic, M. J., Cannon, C. P. & Antman, E. M. The role of cardiac troponin-I (cTnI) in risk stratification of patients with unstable coronary artery disease. Clin Cardiol 22, 13-16 (1999). (Pubitemid 29046990)
12. Tsutamoto, T. et al. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure. Am Heart J 159, 63-67 (2010).
13. Vélez-Martnez, M. et al. Association of cardiac troponin I with disease severity and outcomes in patients with pulmonary hypertension. Am J Cardiol 111, 1812-1817 (2013).
14. Punukollu, G. et al. Elevated serum cardiac troponin I in rhabdomyolysis. Int J Cardiol 96, 35-40 (2004). (Pubitemid 38760236)
15. Abdo, A. S. & Geraci, S. A. Significance of elevated cardiac troponin I in patients with diabetic ketoacidosis. J Miss State Med Assoc 54, 127-130 (2013).
16. Carthew, R. W. & Sontheimer, E. J. Origins and Mechanisms of miRNAs and siRNAs. Cell 136, 642-655 (2009).
17. Eulalio, A. et al. Functional screening identifies miRNAs inducing cardiac regeneration. Nature 492, 376-381 (2012).
18. Hergenreider, E. et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 14, 249-256 (2012).
19. Dorval, V., Nelson, P. T. & Hébert, S. S. Circulating microRNAs in Alzheimer's disease: the search for novel biomarkers. Front Mol Neurosci 6, 24 (2013).
20. Sita-Lumsden, A., Dart, D. A., Waxman, J. & Bevan, C. L. CirculatingmicroRNAs as potential new biomarkers for prostate cancer. Br J Cancer 108, 1925-1930 (2013).
21. van Empel, V. P., De Windt, L. J. & da Costa Martins, P. A. Circulating miRNAs: reflecting or affecting cardiovascular disease? Curr Hypertens Rep 14, 498-509 (2012).
22. Kuster, D. W. et al. MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations. J Mol Cell Cardiol 65C, 59-66 (2013).
23. Karunakaran, D. & Rayner, K. J. MicroRNAs in Cardiovascular Health: From Order to Disorder. Endocrinology 154, 4000-4009 (2013).
24. Asgeirsdo?ttir, S. A. et al. MicroRNA-126 contributes to renal microvascular heterogeneity ofVCAM-1 protein expression in acute inflammation. AmJ Physiol Renal Physiol 302, F1630-1639 (2012).
25. Fang, Y. & Davies, P. F. Site-specific microRNA-92a regulation of Kruppel-like factors 4 and 2 in atherosusceptible endothelium. Arterioscler Thromb Vasc Biol 32, 979-987 (2012).
26. Fichtlscherer, S. et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 107, 677-684 (2010).
27. Liu, X., Cheng, Y., Yang, J., Xu, L. & Zhang, C. Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application. J Mol Cell Cardiol 52, 245-255 (2012).
28. Li, T. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clin Chim Acta 412, 66-70 (2011).
29. Andersson, P. et al. Plasma levels of liver-specific miR-122 is massively increased in a porcine cardiogenic shock model and attenuated by hypothermia. Shock 37, 234-238 (2012).
30. Wang, E. et al. Circulating miRNAs reflect early myocardial injury and recovery after heart transplantation. J Cardiothorac Surg 8, 165 (2013).
31. Goretti, E., Vausort, M., Wagner, D. R. & Devaux, Y. Association between circulating microRNAs, cardiovascular risk factors and outcome in patients with acute myocardial infarction. Int J Cardiol 168, 4548-4550 (2013).
32. Ellis, K. L. et al. Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients. Eur J Heart Fail 15, 1138-1147 (2013).